{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:37:35Z","timestamp":1740109055035,"version":"3.37.3"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00018-021-04014-2","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T17:02:27Z","timestamp":1636131747000},"page":"7991-7999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role for animal models in understanding essential fatty acid deficiency in cystic fibrosis"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1697-8890","authenticated-orcid":false,"given":"Deanne H.","family":"Hryciw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirajan","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Donnelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"McAinch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"4014_CR1","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"JR Riordan","year":"1989","unstructured":"Riordan JR et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066\u20131073","journal-title":"Science"},{"key":"4014_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","volume":"27","author":"G Veit","year":"2016","unstructured":"Veit G et al (2016) From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell 27:424\u2013433","journal-title":"Mol Biol Cell"},{"key":"4014_CR3","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.3390\/ijms22105262","volume":"22","author":"V Capurro","year":"2021","unstructured":"Capurro V et al (2021) Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment. Int J Mol Sci 22:5262","journal-title":"Int J Mol Sci"},{"key":"4014_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.prrv.2012.05.003","volume":"13","author":"FN Dijk","year":"2012","unstructured":"Dijk FN, Fitzgerald DA (2012) The impact of newborn screening and earlier intervention on the clinical course of cystic fibrosis. Paediatr Respir Rev 13:220\u2013225","journal-title":"Paediatr Respir Rev"},{"key":"4014_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC et al (2020) The future of cystic fibrosis care: a global perspective. Lancet Respir Med 8:65\u2013124","journal-title":"Lancet Respir Med"},{"key":"4014_CR6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.chest.2021.06.017","volume":"160","author":"CM Mingora","year":"2021","unstructured":"Mingora CM, Flume PA (2021) Pulmonary complications in cystic fibrosis: past, present and future. Chest 160:1232\u20131240","journal-title":"Chest"},{"issue":"17","key":"4014_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1128\/CMR.17.1.57-71.2004","volume":"2004","author":"L Saiman","year":"2004","unstructured":"Saiman L, Siegel J (2004) Infection control in cystic fibrosis. Clin Microbiol Rev 2004(17):57\u201371","journal-title":"Clin Microbiol Rev"},{"key":"4014_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/ppul.20294","volume":"40","author":"DS Armstrong","year":"2005","unstructured":"Armstrong DS et al (2005) Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 40:500\u2013510","journal-title":"Pediatr Pulmonol"},{"key":"4014_CR9","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/cells9081845","volume":"9","author":"A Mingione","year":"2020","unstructured":"Mingione A et al (2020) Cystic fibrosis defective response to infection involves autophagy and lipid metabolism. Cells 9:1845","journal-title":"Cells"},{"key":"4014_CR10","doi-asserted-by":"publisher","first-page":"16083","DOI":"10.3390\/ijms150916083","volume":"15","author":"AC Seegmiller","year":"2014","unstructured":"Seegmiller AC (2014) Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications. Int J Mol Sci 15:16083\u201316099","journal-title":"Int J Mol Sci"},{"key":"4014_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1203\/00006450-198501000-00028","volume":"19","author":"PM Farrell","year":"1985","unstructured":"Farrell PM et al (1985) Fatty acid abnormalities in cystic fibrosis. Pediatr Res 19:104\u2013109","journal-title":"Pediatr Res"},{"key":"4014_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/ajcn\/69.1.127","volume":"69","author":"M Kalivianakis","year":"1999","unstructured":"Kalivianakis M et al (1999) Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69:127\u2013134","journal-title":"Am J Clin Nutr"},{"key":"4014_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajpath.2020.10.017","volume":"191","author":"A McCarron","year":"2021","unstructured":"McCarron A, Parsons D, Donnelley M (2021) Animal and cell culture models for cystic fibrosis: which model is right for your application? Am J Pathol 191:228\u2013242","journal-title":"Am J Pathol"},{"key":"4014_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0022-3476(62)80065-1","volume":"60","author":"PT Kuo","year":"1962","unstructured":"Kuo PT, Huang NN, Bassett DR (1962) The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas. J Pediatr 60:394\u2013403","journal-title":"J Pediatr"},{"key":"4014_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/BF02536629","volume":"29","author":"AB Christophe","year":"1994","unstructured":"Christophe AB, Warwick WJ, Holman RT (1994) Serum fatty acid profiles in cystic fibrosis patients and their parents. Lipids 29:569\u2013575","journal-title":"Lipids"},{"key":"4014_CR16","unstructured":"Saxby N et al (2017) Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand, in Thoracic Society of Australia and New Zealand, S.C. Bell, Editor: Sydney"},{"key":"4014_CR17","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s13197-012-0677-0","volume":"51","author":"N Kaur","year":"2014","unstructured":"Kaur N, Chugh V, Gupta AK (2014) Essential fatty acids as functional components of foods- a review. J Food Sci Technol 51:2289\u20132303","journal-title":"J Food Sci Technol"},{"key":"4014_CR18","doi-asserted-by":"publisher","first-page":"49512","DOI":"10.1074\/jbc.M309759200","volume":"278","author":"RE Gimeno","year":"2003","unstructured":"Gimeno RE et al (2003) Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J Biol Chem 278:49512\u201349516","journal-title":"J Biol Chem"},{"key":"4014_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/genes11080943","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, Agellon LB (2020) distinct alteration of gene expression programs in the small intestine of male and female mice in response to ablation of intestinal Fabp genes. Genes (Basel) 11:943","journal-title":"Genes (Basel)"},{"key":"4014_CR20","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1113\/JP277583","volume":"597","author":"N Shrestha","year":"2019","unstructured":"Shrestha N et al (2019) Elevated maternal linoleic acid reduces circulating leptin concentrations, cholesterol levels and male fetal survival in a rat model. J Physiol 597:3349\u20133361","journal-title":"J Physiol"},{"key":"4014_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1513\/AnnalsATS.201907-493OC","volume":"17","author":"JK Harris","year":"2020","unstructured":"Harris JK et al (2020) Changes in airway microbiome and inflammation with ivacaftor treatment in patients with cystic fibrosis and the G551D mutation. Ann Am Thorac Soc 17:212\u2013220","journal-title":"Ann Am Thorac Soc"},{"key":"4014_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clnesp.2017.08.008","volume":"22","author":"M Alves Ferreira","year":"2017","unstructured":"Alves Ferreira M et al (2017) Green tea extract outperforms metformin in lipid profile and glycaemic control in overweight women: A double-blind, placebo-controlled, randomized trial. Clin Nutr ESPEN 22:1\u20136","journal-title":"Clin Nutr ESPEN"},{"key":"4014_CR23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3389\/fphar.2020.01290","volume":"11","author":"M Briottet","year":"2020","unstructured":"Briottet M, Shum M, Urbach V (2020) The role of specialized pro-resolving mediators in cystic fibrosis airways disease. Front Pharmacol 11:1290","journal-title":"Front Pharmacol"},{"key":"4014_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ni1056","volume":"5","author":"CL Karp","year":"2004","unstructured":"Karp CL et al (2004) Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 5:388\u2013392","journal-title":"Nat Immunol"},{"key":"4014_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jcf.2017.11.017","volume":"17","author":"FC Ringholz","year":"2018","unstructured":"Ringholz FC et al (2018) Resolvin D1 regulates epithelial ion transport and inflammation in cystic fibrosis airways. J Cyst Fibros 17:607\u2013615","journal-title":"J Cyst Fibros"},{"key":"4014_CR26","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1007\/s00018-020-03530-x","volume":"77","author":"D Gari\u0107","year":"2020","unstructured":"Gari\u0107 D et al (2020) The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide. Cell Mol Life Sci 77:4255\u20134267","journal-title":"Cell Mol Life Sci"},{"key":"4014_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/MPG.0b013e3182618f33","volume":"55","author":"A Maqbool","year":"2012","unstructured":"Maqbool A et al (2012) Relation between dietary fat intake type and serum fatty acid status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 55:605\u2013611","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4014_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1203\/00006450-198601000-00010","volume":"20","author":"EH Mischler","year":"1986","unstructured":"Mischler EH et al (1986) Correction of linoleic acid deficiency in cystic fibrosis. Pediatr Res 20:36\u201341","journal-title":"Pediatr Res"},{"issue":"3","key":"4014_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.plefa.2010.07.002","volume":"83","author":"B Strandvik","year":"2010","unstructured":"Strandvik B (2010) Fatty acid metabolism in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 83(3):121\u2013129","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"4014_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365528809090205","volume":"143","author":"B Strandvik","year":"1988","unstructured":"Strandvik B et al (1988) Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. Scand J Gastroenterol Suppl 143:1\u20134","journal-title":"Scand J Gastroenterol Suppl"},{"key":"4014_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1203\/00006450-198809000-00016","volume":"24","author":"HG Parsons","year":"1988","unstructured":"Parsons HG et al (1988) Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr Res 24:353\u2013356","journal-title":"Pediatr Res"},{"issue":"Suppl 1","key":"4014_CR32","first-page":"16","volume":"58","author":"R Hankard","year":"2002","unstructured":"Hankard R, Munck A, Navarro J (2002) Nutrition and growth in cystic fibrosis. Horm Res 58(Suppl 1):16\u201320","journal-title":"Horm Res"},{"key":"4014_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcn\/34.1.1","volume":"34","author":"JD Lloyd-Still","year":"1981","unstructured":"Lloyd-Still JD, Johnson SB, Holman RT (1981) Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 34:1\u20137","journal-title":"Am J Clin Nutr"},{"key":"4014_CR34","doi-asserted-by":"crossref","unstructured":"Oliver C, Watson H (2016) Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst Rev Cd002201","DOI":"10.1002\/14651858.CD002201.pub5"},{"key":"4014_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jcf.2016.07.006","volume":"16","author":"MG O'Connor","year":"2017","unstructured":"O\u2019Connor MG, Seegmiller A (2017) The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study. J Cyst Fibros 16:132\u2013138","journal-title":"J Cyst Fibros"},{"key":"4014_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/ppul.23972","volume":"53","author":"BT Kopp","year":"2018","unstructured":"Kopp BT et al (2018) Metabolomic responses to lumacaftor\/ivacaftor in cystic fibrosis. Pediatr Pulmonol 53:583\u2013591","journal-title":"Pediatr Pulmonol"},{"key":"4014_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138722","volume":"5","author":"N Liessi","year":"2020","unstructured":"Liessi N et al (2020) Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta. JCI Insight. 5:e138722","journal-title":"JCI Insight."},{"key":"4014_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s42003-020-0909-1","volume":"3","author":"KA Cottrill","year":"2020","unstructured":"Cottrill KA, Farinha CM, McCarty NA (2020) The bidirectional relationship between CFTR and lipids. Commun Biol 3:179","journal-title":"Commun Biol"},{"key":"4014_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1042\/bj2850725","volume":"285","author":"JX Kang","year":"1992","unstructured":"Kang JX et al (1992) The chloride channel blocker anthracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells. Biochem J 285:725\u2013729","journal-title":"Biochem J"},{"key":"4014_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.colsurfb.2009.01.005","volume":"71","author":"K Maky\u0142a","year":"2009","unstructured":"Maky\u0142a K, Paluch M (2009) The linoleic acid influence on molecular interactions in the model of biological membrane. Colloids Surf B Biointerfaces 71:59\u201366","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4014_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1242\/jcs.03350","volume":"120","author":"M Gentzsch","year":"2007","unstructured":"Gentzsch M et al (2007) Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking. J Cell Sci 120:447\u2013455","journal-title":"J Cell Sci"},{"key":"4014_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.97199","volume":"3","author":"SE Birket","year":"2018","unstructured":"Birket SE et al (2018) Development of an airway mucus defect in the cystic fibrosis rat. JCI Insight. 3:e97199","journal-title":"JCI Insight."},{"key":"4014_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-1-61779-120-8_19","volume":"742","author":"JT Fisher","year":"2011","unstructured":"Fisher JT, Zhang Y, Engelhardt JF (2011) Comparative biology of cystic fibrosis animal models. Methods Mol Biol 742:311\u2013334","journal-title":"Methods Mol Biol"},{"key":"4014_CR44","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1002\/j.1460-2075.1995.tb00119.x","volume":"14","author":"JH van Doorninck","year":"1995","unstructured":"van Doorninck JH et al (1995) A mouse model for the cystic fibrosis delta F508 mutation. Embo J 14:4403\u20134411","journal-title":"Embo J"},{"key":"4014_CR45","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1073\/pnas.96.24.13995","volume":"96","author":"SD Freedman","year":"1999","unstructured":"Freedman SD et al (1999) A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-\/-) mice. Proc Natl Acad Sci U S A 96:13995\u201314000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4014_CR46","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1194\/jlr.M400238-JLR200","volume":"45","author":"A Werner","year":"2004","unstructured":"Werner A et al (2004) No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. J Lipid Res 45:2277\u20132286","journal-title":"J Lipid Res"},{"key":"4014_CR47","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3945\/jn.109.110999","volume":"139","author":"M Mimoun","year":"2009","unstructured":"Mimoun M et al (2009) Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid. J Nutr 139:2358\u20132364","journal-title":"J Nutr"},{"key":"4014_CR48","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/1535370218758605","volume":"243","author":"B Strandvik","year":"2018","unstructured":"Strandvik B et al (2018) Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice. Exp Biol Med (Maywood) 243:496\u2013503","journal-title":"Exp Biol Med (Maywood)"},{"key":"4014_CR49","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/MPG.0b013e31817e0f2c","volume":"47","author":"RC De Lisle","year":"2008","unstructured":"De Lisle RC et al (2008) Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine. J Pediatr Gastroenterol Nutr 47:406\u2013416","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4014_CR50","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/j.1460-2075.1996.tb00432.x","volume":"15","author":"SJ Delaney","year":"1996","unstructured":"Delaney SJ et al (1996) Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. Embo J 15:955\u2013963","journal-title":"Embo J"},{"key":"4014_CR51","doi-asserted-by":"publisher","first-page":"L740","DOI":"10.1152\/ajplung.2001.281.3.L740","volume":"281","author":"BJ McMorran","year":"2001","unstructured":"McMorran BJ et al (2001) G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease. Am J Physiol Lung Cell Mol Physiol 281:L740\u2013L747","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4014_CR52","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ajpath.2020.01.009","volume":"190","author":"A McCarron","year":"2020","unstructured":"McCarron A et al (2020) Phenotypic characterization and comparison of cystic fibrosis rat models generated using CRISPR\/Cas9 gene editing. Am J Pathol 190:977\u2013993","journal-title":"Am J Pathol"},{"key":"4014_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ame2.12091","volume":"2","author":"E Dreano","year":"2019","unstructured":"Dreano E et al (2019) Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-generated by Crispr-Cas9. Animal Model Exp Med 2:297\u2013311","journal-title":"Animal Model Exp Med"},{"key":"4014_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091253","volume":"9","author":"KL Tuggle","year":"2014","unstructured":"Tuggle KL et al (2014) Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats. PLoS One. 9:e91253","journal-title":"PLoS One."},{"key":"4014_CR55","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1164\/rccm.202002-0369OC","volume":"202","author":"SE Birket","year":"2020","unstructured":"Birket SE et al (2020) Ivacaftor reverses airway mucus abnormalities in a rat model harboring a humanized G551D-CFTR. Am J Respir Crit Care Med 202:1271\u20131282","journal-title":"Am J Respir Crit Care Med"},{"key":"4014_CR56","doi-asserted-by":"publisher","first-page":"L1093","DOI":"10.1152\/ajplung.00082.2021","volume":"320","author":"M Green","year":"2021","unstructured":"Green M et al (2021) Ivacaftor partially corrects airway inflammation in a humanized G551D rat. Am J Physiol Lung Cell Mol Physiol 320:L1093-l1100","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4014_CR57","doi-asserted-by":"publisher","first-page":"74ra24","DOI":"10.1126\/scitranslmed.3001868","volume":"3","author":"LS Ostedgaard","year":"2011","unstructured":"Ostedgaard LS et al (2011) The \u0394F508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci Transl Med. 3:74ra24","journal-title":"Sci Transl Med."},{"key":"4014_CR58","doi-asserted-by":"publisher","first-page":"29ra31","DOI":"10.1126\/scitranslmed.3000928","volume":"2","author":"DA Stoltz","year":"2010","unstructured":"Stoltz DA et al (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med. 2:29ra31","journal-title":"Sci Transl Med."},{"key":"4014_CR59","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1126\/science.1163600","volume":"321","author":"CS Rogers","year":"2008","unstructured":"Rogers CS et al (2008) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321:1837\u20131841","journal-title":"Science"},{"key":"4014_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123529","volume":"3","author":"Z Fan","year":"2018","unstructured":"Fan Z et al (2018) A sheep model of cystic fibrosis generated by CRISPR\/Cas9 disruption of the CFTR gene. JCI Insight. 3:e123529","journal-title":"JCI Insight."},{"key":"4014_CR61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1165\/rcmb.2014-0250OC","volume":"52","author":"NW Keiser","year":"2015","unstructured":"Keiser NW et al (2015) Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs. Am J Respir Cell Mol Biol 52:683\u2013694","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4014_CR62","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1172\/JCI60610","volume":"122","author":"AK Olivier","year":"2012","unstructured":"Olivier AK et al (2012) Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J Clin Invest 122:3755\u20133768","journal-title":"J Clin Invest"},{"key":"4014_CR63","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1165\/rcmb.2013-0261OC","volume":"50","author":"X Sun","year":"2014","unstructured":"Sun X et al (2014) Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets. Am J Respir Cell Mol Biol 50:502\u2013512","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4014_CR64","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","volume":"15","author":"L Hodson","year":"2019","unstructured":"Hodson L, Gunn PJ (2019) The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state. Nat Rev Endocrinol 15:689\u2013700","journal-title":"Nat Rev Endocrinol"},{"key":"4014_CR65","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/ijms21041362","volume":"21","author":"JK Innes","year":"2020","unstructured":"Innes JK, Calder PC (2020) Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020. Int J Mol Sci 21:1362","journal-title":"Int J Mol Sci"},{"key":"4014_CR66","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1172\/JCI119861","volume":"100","author":"G Kent","year":"1997","unstructured":"Kent G et al (1997) Lung disease in mice with cystic fibrosis. J Clin Invest 100:3060\u20133069","journal-title":"J Clin Invest"},{"key":"4014_CR67","doi-asserted-by":"publisher","first-page":"G839","DOI":"10.1152\/ajpgi.00582.2005","volume":"292","author":"S Beharry","year":"2007","unstructured":"Beharry S et al (2007) Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 292:G839\u2013G848","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-04014-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-04014-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-04014-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T18:33:15Z","timestamp":1675881195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-04014-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":67,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4014"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-04014-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"type":"print","value":"1420-682X"},{"type":"electronic","value":"1420-9071"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"17 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest with the content of this manuscript. Any potential conflicts of interest among all authors related to funding or other financial agreements will be collected and updated during the review process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}